Four Signals Behind WholeFoods September New Product List
The WholeFoods Magazine September new product list is an annual barometer for the North American natural products industry. Looking through this issue, the products are extremely diverse: mushroom lattes, electrolyte coconut water, immune-support mushrooms for pets, organ supplements for women, clean-label-certified plant capsules… None of them is special on its own, but taken together, the shift in the industry’s rules of the game is very clear – clean labels have gone from a plus point to an admission ticket; functionality has moved from bottles and jars into daily food and drinks; mushrooms have spread from human products to pet products; and products have shifted from “covering everything” to “targeting specific people.”
As someone who has long followed the overseas expansion of plant extracts and functional ingredients, I do not want to stop at listing the products. Instead, I want to break down four of these signals and talk about what they really mean for Chinese companies like us that make raw materials and ingredients.
1. Clean Labels Have Become a Hard Threshold: Benefits and Pressure Arrive at the Same Time
Nearly every product on this list carries a “no artificial ingredients / gluten-free / non-GMO” label. Ten years ago, these were points of differentiation; today they are just the minimum standard on the shelf and no longer worth mentioning separately.
The change that really deserves attention happened on the ingredient side: ACG launched ACGcaps H+, which it claims is the world’s first HPMC plant-based empty capsule certified by the Clean Label Project, and it even offers a titanium-dioxide-free opacifying option. NurtureBio’s synbiotic product, on the other hand, received the Clean Label Project Purity Award – this award does not check the things written on labels, but pollutants such as heavy metals, pesticide residues, plasticizers and bisphenol A, which ordinary consumers have no way to verify and which labels never disclose.
Put the two together, and the word “clean” has been redefined overseas: it has moved from clean finished formulas to clean packaging and excipients, and from “what is not written on the label” to “what must be absent from the test report.”
For Chinese plant extract and functional ingredient companies, this is both a benefit and a pressure. It is a benefit because natural sources are indeed our home turf – take white orchid concrete (Michelia alba), a natural fragrance material, as an example: the approach of “natural fragrance + clean label” is completely in line with this overseas trend. It is pressure because “clean” cannot be proven by words alone. The pollutants that the Clean Label Project checks – heavy metals, pesticide residues, plasticizers, bisphenols – are exactly the areas where domestic raw materials are most likely to be stopped by random inspections on the export end, and where brands use “insufficient data” as an excuse to switch suppliers.
The conclusion is straightforward: clean labels are the ticket, and test data are the seal on the ticket. When overseas brands choose suppliers, they no longer look at your brochure, but at how many third-party test reports you can provide and in what dimensions. The reason this has not yet pressed on us is simply that transmission lags behind; sooner or later this pressure will reach the raw material end – companies that make testing capability a standard feature early will enter the next round first.
2. Functionality Goes Daily: Hiding the “Medicine” in Food and Drinks, Building Repurchase into Scenarios
My most direct impression of this issue’s functional products is that none of them looks like a supplement anymore. There is a mushroom latte (a mix of lion’s mane, reishi, chaga and cordyceps), Celestial Seasonings’ prebiotic herbal teas, Real Coco’s electrolyte coconut water, and Cheribundi’s tart cherry recovery drink. The functionality is still there, but the carriers are all daily food and drinks – coffee, tea, water and juice.
Behind this is a shift in consumer mentality: the public wants functionality, but strongly dislikes the “feeling of taking medicine.” Swallowing capsules on a fixed schedule, counting doses and checking the time every day is a burden; getting your nutrition by simply drinking a cup of coffee or opening a bottle of water is the way people are willing to pay for over the long term.
Once the carrier of functionality changes, the business logic changes too – supplements are a category with low purchase frequency, strong motivation and high decision cost, while daily consumer goods are a category with high frequency, weak motivation and low threshold. The same gram of active ingredient, sold in a capsule to the supplement crowd, or dissolved in a bottle of electrolyte water for all sports consumers – the market capacity is simply not on the same scale.
For Chinese companies, the real opportunity in this track lies in “translation capability.” We do not lack a library of functional raw materials – herbal extracts, tea polyphenols, goji berries, ginseng, reishi and turmeric; every one of them has a story to tell on its own. What we lack is the ability to translate them into overseas daily scenarios: reishi + coffee is already a mature category in Europe and America, so can our raw materials get into their lattes, sparkling water, smoothies and energy bars? In the second half of the raw material going-global story, what we sell is no longer “the extract itself,” but “which daily scenario this extract can bind to, which category it can enter, and whether it can help the brand tell a complete story.”
3. Pets: An Exit That Is Looser, Faster and More Willing to Spend
On this list, pet products compete on the same stage as human products, and their weight is not light: Host Defense launched a pet-specific immune product with a blend of five mushrooms; ADM’s PRIOME postbiotic for metabolic health won the 2026 Pet Innovation Award for “Annual Canine Preventive Product,” targeting normal blood sugar and metabolic balance in dogs. The fact that big players are all stepping in shows that pet nutrition is no longer just an extension of the pet food category – it has become an independent and serious functional nutrition track.
Why do I say pets are a new blue ocean for plant extract exports? There are three reasons.
First, the gap between regulation and entry barriers. The human-use market is already extremely crowded and strictly regulated – new ingredients need approval, functional claims need evidence, and the cycle is long and costly; pet nutrition regulation in Europe and America is relatively loose, product iteration is fast, and Chinese companies entering as ingredient suppliers face far less resistance than in human-use raw materials.
Second, pet humanization is an irreversible consumption trend. Families in Europe and America treat pets as “furry children” and are willing to pay for “human-grade” nutrition solutions. Concepts like postbiotics, mushroom polysaccharides and natural extracts have already completed market education on the pet side – there is no need to start from zero.
Third, the directions match highly. ADM’s work on canine blood sugar and metabolism, and Host Defense’s work on pet immunity, happen to be the fields where natural ingredients like reishi, fungal polysaccharides and postbiotics can work best – the technical reserves on the raw material side are almost ready-made.
But there is a reminder: pets do not equal “downgraded human formulas.” Overseas buyers want solutions for pets’ life stages and specific health problems, not a human formula cut in half and sold cheap. Whoever treats pets seriously as an independent market – building product logic by breed, age and health issues – will get to taste this wave of dividends; whoever treats it as a clearance market will only be seen as a low-price supplier.
4. Segmented Groups Are Worth More Than “One-Size-Fits-All”
The most “aggressive” products in this issue are almost all anchored to specific groups: Women Bloom’s bovine organ supplement targets women (bovine ovary and uterine tissue plus collagen); VeriPalmetto saw palmetto goes for men’s health; purple corn anthocyanin PCE-PRO uses a single standardized plant extract to position itself for two groups at once – prostate and eye health. Note that PCE-PRO’s dual positioning is not marketing talk – it claims to have completed two human clinical trials: one raw material, two target groups, two sets of evidence.
This gives us a very practical insight: the overseas market is shifting from “general functions” to “specific people.” Making a broad claim like “boost immunity” puts you against every brand in the whole category, and in the end you fight on price and channels; but doing “nighttime troubles of men over 50,” “gut comfort for pregnant women,” or “joint care for sports people” narrows the competition instantly – you can give users a clear reason to choose you, and the premium comes with it.
For Chinese companies, this logic can be condensed into a methodology: do not make universal products; make “a certain problem of a certain group.” Women, senior citizens, children and sports people are all clear entry points; each entry point has clear pain points and scenarios, and differentiation and evidence building on the raw material side are easier to focus than “one-size-fits-all.” Clinical data will increasingly become the hard currency of segmented positioning – ten functional claims are less convincing than one clinical study targeting the group in question.
Connect the four signals, and there is only one main line: the dimension of competition in the natural products industry has upgraded from “are the ingredients good enough” to “is trust sufficient, are the scenarios clever enough, and are the target groups accurate enough.”
Clean labels are the admission ticket to trust, functional daily life is the entrance to scenarios, pets are the incremental market, and segmented groups are the barrier of differentiation. For plant extract raw materials and functional ingredient companies, the essence of going global is also changing: it is no longer the business of “selling raw materials”, but the business of “selling solutions” – botanical extracts systems solutions packed with test data, scenario adaptation and group evidence.
In this round, it is not about who has more ingredients, but who has harder evidence, more precise scenarios and sharper targeting. Whoever bets heavily on these three things first will get the ticket to the next cycle.
